Cristina Tresoldi Selected Research

Cristina Tresoldi Research Topics

Disease

19	COVID-19 11/2023 - 12/2020
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2006
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 01/2009
5	Neoplasms (Cancer) 01/2018 - 01/2006
4	Leukemia 08/2016 - 01/2006
3	Hypoxia (Hypoxemia) 11/2023 - 08/2016
3	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Infections 01/2023 - 01/2021
2	Multiple Myeloma 01/2022 - 01/2018
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 01/2021
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2016 - 02/2013
1	Acute Promyelocytic Leukemia 11/2023
1	Inflammation (Inflammations) 01/2023
1	Human Influenza (Influenza) 10/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022
1	Virus Diseases (Viral Diseases) 10/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Residual Neoplasm 01/2022
1	Reinfection 01/2021
1	Hyperglycemia 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2016

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2006
5	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 01/2009
5	Testosterone (Sustanon)FDA Link 11/2023 - 01/2021
3	AntibodiesIBA 10/2022 - 12/2020
3	AntigensIBA 11/2021 - 01/2009
3	CytokinesIBA 10/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 08/2016
2	Interferon Type IIBA 01/2023 - 10/2022
2	AutoantibodiesIBA 01/2023 - 01/2021
2	HLA-G Antigens (HLA G)IBA 01/2023 - 01/2014
2	Chromogranin AIBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 12/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2022 - 10/2021
2	Neutralizing AntibodiesIBA 11/2021 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 02/2013
1	Proton Pump InhibitorsIBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	InterleukinsIBA 01/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	EnzymesIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	P-2 (P 2)IBA 10/2022
1	C-Reactive ProteinIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	von Willebrand FactorIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Hemagglutinins (Hemagglutinin)IBA 11/2021
1	NucleoproteinsIBA 11/2021
1	IronIBA 10/2021
1	AdipokinesIBA 10/2021
1	CreatinineIBA 10/2021
1	lactate dehydrogenase C4IBA 10/2021
1	AlarminsIBA 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	SteroidsIBA 01/2021
1	VaccinesIBA 01/2021
1	AndrogensIBA 01/2021
1	LuciferasesIBA 12/2020
1	Immunoglobulin M (IgM)IBA 12/2020
1	Immunoglobulin A (IgA)IBA 12/2020
1	Immunomodulating AgentsIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 06/2016
1	Interleukin-22 (IL-22)IBA 05/2015
1	Thymidine KinaseIBA 02/2013
1	Ganciclovir (Cytovene)FDA LinkGeneric 02/2013
1	ProdrugsIBA 02/2013
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2009

Therapy/Procedure

7	Hematopoietic Stem Cell Transplantation 01/2018 - 01/2006
5	Therapeutics 01/2022 - 05/2012
2	Transplantation 10/2022 - 01/2018
1	Drug Therapy (Chemotherapy) 11/2023
1	Length of Stay 06/2022
1	Induction Chemotherapy 01/2018
1	Homologous Transplantation 10/2014